<--- Back to Details
First PageDocument Content
Bacterial diseases / Proteobacteria / Meningococcal disease / Vaccines / Neisseria meningitidis / Meningitis / Neisseria / Purpura / Meningococcal septicaemia / Bacteria / Microbiology / Medicine
Date: 2011-01-07 11:31:31
Bacterial diseases
Proteobacteria
Meningococcal disease
Vaccines
Neisseria meningitidis
Meningitis
Neisseria
Purpura
Meningococcal septicaemia
Bacteria
Microbiology
Medicine

Microsoft Word - meningococcal.docx

Add to Reading List

Source URL: www.maine.gov

Download Document from Source Website

File Size: 13,05 KB

Share Document on Facebook

Similar Documents

Purpura, J.K., S. Cobb, P. T. Marsh, and M. J. Hudson, 2012: The NWS and VORTEX2: Facilitating real-time communication between research and warning operations. Electronic J. Operational Meteor., 13 (8), 108119. ––

DocID: 1v6P1 - View Document

Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero Cataland, Flora Peyvandi, Paul Coppo,

DocID: 1utac - View Document

Disponible en España romiplostim, primer estimulador de producción de plaquetas sanguíneas Romiplostim representa un importante avance en el tratamiento de la Púrpura Trombocitopénica Inmune (PTI), una rara enfermed

DocID: 1sfuy - View Document

THREE RIDGES, NELLYSFORD, VA. PHOTO BY PAUL PURPURA | PAULPURPURAPHOTOGRAPHY.COM a mom & pop since 2005 TM

DocID: 1r9WZ - View Document

Medicine / Blood / Clinical medicine / Transfusion medicine / Immune thrombocytopenic purpura / Orphan drugs / Thrombocytopenia / Platelet / Romiplostim / Megakaryocyte / Glycoprotein Ib / Autoimmunity

· THROMBOCY TOPENIA · Complement Blockade with C1 Esterase Inhibitor in Refractory Immune Thrombocytopenia Erin Roesch, MD, and Catherine Broome, MD

DocID: 1q1KX - View Document